作者：
Pitt,B. [1]
;
Kober,L. [2]
;
Ponikowski,P. [3]
;
Gheorghiade,M. [4]
;
Filippatos,G. [5]
;
Krum,H. [6]
;
Nowack,C. [7]
;
Kolkhof,P. [8]
;
Kim,S.-Y. [9]
;
Zannad,F. [10]
作者单位：
University of Michigan, School of Medicine, Ann Arbor, MI, United States
[1]
Heart Failure Unit, Department of Cardiology, Attikon University Hospital, Athens, Greece
[2]
Department of Epidemiology and Preventive Medicine, Centre of Cardiovascular Research and Education
[3]
Cardiology Research, Global Drug Development, Bayer Pharma AG, Wuppertal, Germany
[4]
INSERM, Centre d'Investigation Clinique 9501 and Unit 961, Université de Lorraine, Nancy, France
[5]
Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago
[6]
Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
[7]
Medical University, Clinical Military Hospital, Wroclaw, Poland
[8]
Global Clinical Development, Bayer Pharma AG, Wuppertal, Germany
[9]
Bayer Vital GmbH, Bayer HealthCare, Leverkusen, Germany
[10]
发布时间
2013-11-20
换一批
